http://www.mypharma-editions.com L'Info Industrie & Politique de Santé Wed, 15 Feb 2012 14:04:44 +0000 en hourly 1 http://wordpress.org/?v=3.3.1 http://www.mypharma-editions.com/merck-et-supera-farma-creent-une-coentreprise-au-bresil http://www.mypharma-editions.com/merck-et-supera-farma-creent-une-coentreprise-au-bresil#comments Wed, 15 Feb 2012 14:04:10 +0000 morgdave http://www.mypharma-editions.com/?p=23434 http://www.mypharma-editions.com/merck-et-supera-farma-creent-une-coentreprise-au-bresil/feed 0 http://www.mypharma-editions.com/quintiles-elargit-ses-services-commerciaux-sur-les-marches-du-moyen-orient-et-de-lafrique-du-nord http://www.mypharma-editions.com/quintiles-elargit-ses-services-commerciaux-sur-les-marches-du-moyen-orient-et-de-lafrique-du-nord#comments Wed, 15 Feb 2012 08:10:04 +0000 morgdave http://www.mypharma-editions.com/?p=23429 http://www.mypharma-editions.com/quintiles-elargit-ses-services-commerciaux-sur-les-marches-du-moyen-orient-et-de-lafrique-du-nord/feed 0 http://www.mypharma-editions.com/biogen-idec-va-acquerir-stromedix http://www.mypharma-editions.com/biogen-idec-va-acquerir-stromedix#comments Tue, 14 Feb 2012 17:08:58 +0000 morgdave http://www.mypharma-editions.com/?p=23426 http://www.mypharma-editions.com/biogen-idec-va-acquerir-stromedix/feed 0 http://www.mypharma-editions.com/sanofi-franck-le-meur-est-nomme-directeur-des-operations-generiques-zentiva-france http://www.mypharma-editions.com/sanofi-franck-le-meur-est-nomme-directeur-des-operations-generiques-zentiva-france#comments Tue, 14 Feb 2012 08:14:54 +0000 morgdave http://www.mypharma-editions.com/?p=23417 http://www.mypharma-editions.com/sanofi-franck-le-meur-est-nomme-directeur-des-operations-generiques-zentiva-france/feed 0 http://www.mypharma-editions.com/vih-innavirvax-annonce-une-levee-de-fonds-de-37-millions-deuros http://www.mypharma-editions.com/vih-innavirvax-annonce-une-levee-de-fonds-de-37-millions-deuros#comments Mon, 13 Feb 2012 15:06:12 +0000 morgdave http://www.mypharma-editions.com/?p=23410 http://www.mypharma-editions.com/vih-innavirvax-annonce-une-levee-de-fonds-de-37-millions-deuros/feed 0 http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad#comments Mon, 13 Feb 2012 09:50:44 +0000 morgdave http://www.mypharma-editions.com/?p=23407 http://www.mypharma-editions.com/maladies-auto-immunes-effimune-recoit-un-soutien-financier-de-lue-pour-le-projet-triad/feed 0 http://www.mypharma-editions.com/ucb-et-nodality-concluent-une-collaboration-strategique-de-plusieurs-annees http://www.mypharma-editions.com/ucb-et-nodality-concluent-une-collaboration-strategique-de-plusieurs-annees#comments Mon, 13 Feb 2012 08:50:48 +0000 morgdave http://www.mypharma-editions.com/?p=23401 http://www.mypharma-editions.com/ucb-et-nodality-concluent-une-collaboration-strategique-de-plusieurs-annees/feed 0 http://www.mypharma-editions.com/janssen-valerie-perruchot-garcia-nommee-directeur-des-affaires-publiques-et-de-la-communication http://www.mypharma-editions.com/janssen-valerie-perruchot-garcia-nommee-directeur-des-affaires-publiques-et-de-la-communication#comments Fri, 10 Feb 2012 12:23:31 +0000 morgdave http://www.mypharma-editions.com/?p=23393 http://www.mypharma-editions.com/janssen-valerie-perruchot-garcia-nommee-directeur-des-affaires-publiques-et-de-la-communication/feed 0 http://www.mypharma-editions.com/infertilite-ferring-annonce-une-nouvelle-initiative-de-sensibilisation-dun-million-deuros http://www.mypharma-editions.com/infertilite-ferring-annonce-une-nouvelle-initiative-de-sensibilisation-dun-million-deuros#comments Thu, 09 Feb 2012 16:18:57 +0000 morgdave http://www.mypharma-editions.com/?p=23384 http://www.mypharma-editions.com/infertilite-ferring-annonce-une-nouvelle-initiative-de-sensibilisation-dun-million-deuros/feed 0 http://www.mypharma-editions.com/presidentielle-2012-le-leem-soumet-quatre-propositions-aux-candidats http://www.mypharma-editions.com/presidentielle-2012-le-leem-soumet-quatre-propositions-aux-candidats#comments Thu, 09 Feb 2012 16:12:05 +0000 morgdave http://www.mypharma-editions.com/?p=23382 http://www.mypharma-editions.com/presidentielle-2012-le-leem-soumet-quatre-propositions-aux-candidats/feed 0 http://www.mypharma-editions.com/pharnext-leve-8-millions-deuros-supplementaires-pour-sa-plateforme-de-pleotherapie http://www.mypharma-editions.com/pharnext-leve-8-millions-deuros-supplementaires-pour-sa-plateforme-de-pleotherapie#comments Thu, 09 Feb 2012 09:47:36 +0000 morgdave http://www.mypharma-editions.com/?p=23378 http://www.mypharma-editions.com/pharnext-leve-8-millions-deuros-supplementaires-pour-sa-plateforme-de-pleotherapie/feed 0 http://www.mypharma-editions.com/le-primperan-et-ses-generiques-contre-indiques-chez-les-moins-de-18-ans http://www.mypharma-editions.com/le-primperan-et-ses-generiques-contre-indiques-chez-les-moins-de-18-ans#comments Thu, 09 Feb 2012 08:54:37 +0000 morgdave http://www.mypharma-editions.com/?p=23374 http://www.mypharma-editions.com/le-primperan-et-ses-generiques-contre-indiques-chez-les-moins-de-18-ans/feed 0 http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche#comments Thu, 09 Feb 2012 08:30:20 +0000 morgdave http://www.mypharma-editions.com/?p=23372 http://www.mypharma-editions.com/cancer-du-sein-la-fda-accorde-une-procedure-dexamen-prioritaire-au-pertuzumab-de-roche/feed 0 http://www.mypharma-editions.com/immunotherapie-en-france-un-constat-mitige-selon-une-etude-du-leem http://www.mypharma-editions.com/immunotherapie-en-france-un-constat-mitige-selon-une-etude-du-leem#comments Wed, 08 Feb 2012 17:53:18 +0000 morgdave http://www.mypharma-editions.com/?p=23369 http://www.mypharma-editions.com/immunotherapie-en-france-un-constat-mitige-selon-une-etude-du-leem/feed 0 http://www.mypharma-editions.com/publicite-les-investissements-de-la-pharma-en-presse-medicale-en-baisse-de-4-sur-12-mois http://www.mypharma-editions.com/publicite-les-investissements-de-la-pharma-en-presse-medicale-en-baisse-de-4-sur-12-mois#comments Wed, 08 Feb 2012 11:25:57 +0000 morgdave http://www.mypharma-editions.com/?p=23366 http://www.mypharma-editions.com/publicite-les-investissements-de-la-pharma-en-presse-medicale-en-baisse-de-4-sur-12-mois/feed 0 http://www.mypharma-editions.com/le-beneficerisque-de-stablon-de-servier-reste-favorable http://www.mypharma-editions.com/le-beneficerisque-de-stablon-de-servier-reste-favorable#comments Wed, 08 Feb 2012 11:06:20 +0000 morgdave http://www.mypharma-editions.com/?p=23362 http://www.mypharma-editions.com/le-beneficerisque-de-stablon-de-servier-reste-favorable/feed 0 http://www.mypharma-editions.com/sanofi-positionne-pour-une-periode-de-croissance-durable http://www.mypharma-editions.com/sanofi-positionne-pour-une-periode-de-croissance-durable#comments Wed, 08 Feb 2012 09:13:31 +0000 morgdave http://www.mypharma-editions.com/?p=23360 http://www.mypharma-editions.com/sanofi-positionne-pour-une-periode-de-croissance-durable/feed 0 http://www.mypharma-editions.com/sanofi-et-bristol-myers-squibb-recoivent-4422-millions-de-dollars-dapotex-dans-le-litige-plavix http://www.mypharma-editions.com/sanofi-et-bristol-myers-squibb-recoivent-4422-millions-de-dollars-dapotex-dans-le-litige-plavix#comments Wed, 08 Feb 2012 08:47:02 +0000 morgdave http://www.mypharma-editions.com/?p=23358 http://www.mypharma-editions.com/sanofi-et-bristol-myers-squibb-recoivent-4422-millions-de-dollars-dapotex-dans-le-litige-plavix/feed 0 http://www.mypharma-editions.com/le-genopole-pilote-la-formation-dacteurs-dun-biocluster-polonais http://www.mypharma-editions.com/le-genopole-pilote-la-formation-dacteurs-dun-biocluster-polonais#comments Tue, 07 Feb 2012 14:32:34 +0000 morgdave http://www.mypharma-editions.com/?p=23355 http://www.mypharma-editions.com/le-genopole-pilote-la-formation-dacteurs-dun-biocluster-polonais/feed 0 http://www.mypharma-editions.com/migraine-lafssaps-emet-des-reserves-sur-le-desernil http://www.mypharma-editions.com/migraine-lafssaps-emet-des-reserves-sur-le-desernil#comments Tue, 07 Feb 2012 10:11:48 +0000 morgdave http://www.mypharma-editions.com/?p=23345 http://www.mypharma-editions.com/migraine-lafssaps-emet-des-reserves-sur-le-desernil/feed 0 http://www.mypharma-editions.com/alize-pharma-cede-une-licence-a-eusa-pharma-sur-son-programme-asparec http://www.mypharma-editions.com/alize-pharma-cede-une-licence-a-eusa-pharma-sur-son-programme-asparec#comments Mon, 06 Feb 2012 15:01:36 +0000 morgdave http://www.mypharma-editions.com/?p=23341 http://www.mypharma-editions.com/alize-pharma-cede-une-licence-a-eusa-pharma-sur-son-programme-asparec/feed 0 http://www.mypharma-editions.com/sanofi-pasteur-et-le-centre-national-detudes-spatiales-sallient-pour-lutter-contre-la-dengue http://www.mypharma-editions.com/sanofi-pasteur-et-le-centre-national-detudes-spatiales-sallient-pour-lutter-contre-la-dengue#comments Mon, 06 Feb 2012 12:11:20 +0000 morgdave http://www.mypharma-editions.com/?p=23338 http://www.mypharma-editions.com/sanofi-pasteur-et-le-centre-national-detudes-spatiales-sallient-pour-lutter-contre-la-dengue/feed 0 http://www.mypharma-editions.com/diabete-adocia-recoit-10-m-au-titre-de-son-accord-de-licence-avec-eli-lilly http://www.mypharma-editions.com/diabete-adocia-recoit-10-m-au-titre-de-son-accord-de-licence-avec-eli-lilly#comments Mon, 06 Feb 2012 09:40:38 +0000 morgdave http://www.mypharma-editions.com/?p=23335 http://www.mypharma-editions.com/diabete-adocia-recoit-10-m-au-titre-de-son-accord-de-licence-avec-eli-lilly/feed 0 http://www.mypharma-editions.com/inra-et-pfizer-signent-un-accord-cadre-en-sante-animale http://www.mypharma-editions.com/inra-et-pfizer-signent-un-accord-cadre-en-sante-animale#comments Fri, 03 Feb 2012 09:08:12 +0000 morgdave http://www.mypharma-editions.com/?p=23322 http://www.mypharma-editions.com/inra-et-pfizer-signent-un-accord-cadre-en-sante-animale/feed 0 http://www.mypharma-editions.com/automedication-un-des-seuls-marches-dynamiques-du-medicament-en-2011 http://www.mypharma-editions.com/automedication-un-des-seuls-marches-dynamiques-du-medicament-en-2011#comments Fri, 03 Feb 2012 08:45:47 +0000 morgdave http://www.mypharma-editions.com/?p=23317 http://www.mypharma-editions.com/automedication-un-des-seuls-marches-dynamiques-du-medicament-en-2011/feed 0 http://www.mypharma-editions.com/roche-mise-sur-une-nouvelle-croissance-des-ventes-en-2012 http://www.mypharma-editions.com/roche-mise-sur-une-nouvelle-croissance-des-ventes-en-2012#comments Thu, 02 Feb 2012 09:42:48 +0000 morgdave http://www.mypharma-editions.com/?p=23311 http://www.mypharma-editions.com/roche-mise-sur-une-nouvelle-croissance-des-ventes-en-2012/feed 0 http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib#comments Thu, 02 Feb 2012 09:05:11 +0000 morgdave http://www.mypharma-editions.com/?p=23309 http://www.mypharma-editions.com/ab-science-annonce-de-nouveaux-resultats-cliniques-pour-masitinib/feed 0 http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle#comments Wed, 01 Feb 2012 15:55:41 +0000 morgdave http://www.mypharma-editions.com/?p=23306 http://www.mypharma-editions.com/neurosciences-pfizer-et-licm-annoncent-une-collaboration-de-recherche-translationelle/feed 0 http://www.mypharma-editions.com/lindustrie-pharmaceutique-va-interpeller-les-candidats-a-la-presidentielle http://www.mypharma-editions.com/lindustrie-pharmaceutique-va-interpeller-les-candidats-a-la-presidentielle#comments Wed, 01 Feb 2012 11:30:30 +0000 morgdave http://www.mypharma-editions.com/?p=23296 http://www.mypharma-editions.com/lindustrie-pharmaceutique-va-interpeller-les-candidats-a-la-presidentielle/feed 0 http://www.mypharma-editions.com/polyarthrite-rhumatoide-accord-entre-astellas-et-ucb-pour-commercialiser-cimzia-au-japon http://www.mypharma-editions.com/polyarthrite-rhumatoide-accord-entre-astellas-et-ucb-pour-commercialiser-cimzia-au-japon#comments Wed, 01 Feb 2012 09:33:26 +0000 morgdave http://www.mypharma-editions.com/?p=23293 http://www.mypharma-editions.com/polyarthrite-rhumatoide-accord-entre-astellas-et-ucb-pour-commercialiser-cimzia-au-japon/feed 0 http://www.mypharma-editions.com/merck-serono-va-multiplier-par-dix-sa-donation-annuelle-de-comprimes-de-praziquantel http://www.mypharma-editions.com/merck-serono-va-multiplier-par-dix-sa-donation-annuelle-de-comprimes-de-praziquantel#comments Wed, 01 Feb 2012 09:06:59 +0000 morgdave http://www.mypharma-editions.com/?p=23290 http://www.mypharma-editions.com/merck-serono-va-multiplier-par-dix-sa-donation-annuelle-de-comprimes-de-praziquantel/feed 0 http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer#comments Wed, 01 Feb 2012 08:56:03 +0000 morgdave http://www.mypharma-editions.com/?p=23288 http://www.mypharma-editions.com/maladies-metaboliques-kinemed-annonce-sa-collaboration-avec-pfizer/feed 0 http://www.mypharma-editions.com/transgene-franchit-deux-nouvelles-etapes-pour-ses-activites-en-chine http://www.mypharma-editions.com/transgene-franchit-deux-nouvelles-etapes-pour-ses-activites-en-chine#comments Tue, 31 Jan 2012 09:29:31 +0000 morgdave http://www.mypharma-editions.com/?p=23282 http://www.mypharma-editions.com/transgene-franchit-deux-nouvelles-etapes-pour-ses-activites-en-chine/feed 0 http://www.mypharma-editions.com/maladie-de-parkinson-domain-therapeutics-obtient-une-subvention-de-la-fondation-michael-j-fox http://www.mypharma-editions.com/maladie-de-parkinson-domain-therapeutics-obtient-une-subvention-de-la-fondation-michael-j-fox#comments Tue, 31 Jan 2012 09:17:51 +0000 morgdave http://www.mypharma-editions.com/?p=23278 http://www.mypharma-editions.com/maladie-de-parkinson-domain-therapeutics-obtient-une-subvention-de-la-fondation-michael-j-fox/feed 0 http://www.mypharma-editions.com/sanofi-sengage-a-eliminer-ou-controler-cinq-maladies-tropicales-negligees http://www.mypharma-editions.com/sanofi-sengage-a-eliminer-ou-controler-cinq-maladies-tropicales-negligees#comments Tue, 31 Jan 2012 08:39:01 +0000 morgdave http://www.mypharma-editions.com/?p=23268 http://www.mypharma-editions.com/sanofi-sengage-a-eliminer-ou-controler-cinq-maladies-tropicales-negligees/feed 0 http://www.mypharma-editions.com/roche-feu-vert-de-la-fda-pour-erivedge-dans-le-carcinome-basocellulaire-avance http://www.mypharma-editions.com/roche-feu-vert-de-la-fda-pour-erivedge-dans-le-carcinome-basocellulaire-avance#comments Tue, 31 Jan 2012 08:18:22 +0000 morgdave http://www.mypharma-editions.com/?p=23266 http://www.mypharma-editions.com/roche-feu-vert-de-la-fda-pour-erivedge-dans-le-carcinome-basocellulaire-avance/feed 0 http://www.mypharma-editions.com/robert-chu-nomme-president-dims-health-france http://www.mypharma-editions.com/robert-chu-nomme-president-dims-health-france#comments Mon, 30 Jan 2012 17:11:59 +0000 morgdave http://www.mypharma-editions.com/?p=23260 http://www.mypharma-editions.com/robert-chu-nomme-president-dims-health-france/feed 0 http://www.mypharma-editions.com/biogen-idec-kenneth-dipietro-nomme-vice-president-executif-des-ressources-humaines http://www.mypharma-editions.com/biogen-idec-kenneth-dipietro-nomme-vice-president-executif-des-ressources-humaines#comments Mon, 30 Jan 2012 14:50:54 +0000 morgdave http://www.mypharma-editions.com/?p=23251 http://www.mypharma-editions.com/biogen-idec-kenneth-dipietro-nomme-vice-president-executif-des-ressources-humaines/feed 0 http://www.mypharma-editions.com/maladies-tropicales-negligees-lindustrie-pharmaceutique-promet-un-don-de-14-milliards-de-traitements http://www.mypharma-editions.com/maladies-tropicales-negligees-lindustrie-pharmaceutique-promet-un-don-de-14-milliards-de-traitements#comments Mon, 30 Jan 2012 13:18:29 +0000 morgdave http://www.mypharma-editions.com/?p=23249 http://www.mypharma-editions.com/maladies-tropicales-negligees-lindustrie-pharmaceutique-promet-un-don-de-14-milliards-de-traitements/feed 1 http://www.mypharma-editions.com/hormone-de-croissance-chez-lenfant-la-has-pour-le-maintien-au-remboursement http://www.mypharma-editions.com/hormone-de-croissance-chez-lenfant-la-has-pour-le-maintien-au-remboursement#comments Mon, 30 Jan 2012 10:03:28 +0000 morgdave http://www.mypharma-editions.com/?p=23240 http://www.mypharma-editions.com/hormone-de-croissance-chez-lenfant-la-has-pour-le-maintien-au-remboursement/feed 0 http://www.mypharma-editions.com/biotechs-amgen-rachete-micromet-pour-116-milliard-de-dollars http://www.mypharma-editions.com/biotechs-amgen-rachete-micromet-pour-116-milliard-de-dollars#comments Mon, 30 Jan 2012 09:34:17 +0000 morgdave http://www.mypharma-editions.com/?p=23237 http://www.mypharma-editions.com/biotechs-amgen-rachete-micromet-pour-116-milliard-de-dollars/feed 0 http://www.mypharma-editions.com/antitrust-la-commission-europeenne-clot-une-procedure-ouverte-a-lencontre-de-servier http://www.mypharma-editions.com/antitrust-la-commission-europeenne-clot-une-procedure-ouverte-a-lencontre-de-servier#comments Fri, 27 Jan 2012 14:30:18 +0000 morgdave http://www.mypharma-editions.com/?p=23230 http://www.mypharma-editions.com/antitrust-la-commission-europeenne-clot-une-procedure-ouverte-a-lencontre-de-servier/feed 0 http://www.mypharma-editions.com/biotechs-rhenovia-pharma-ouvre-sa-premiere-filiale-internationale-aux-etats-unis http://www.mypharma-editions.com/biotechs-rhenovia-pharma-ouvre-sa-premiere-filiale-internationale-aux-etats-unis#comments Fri, 27 Jan 2012 14:17:31 +0000 morgdave http://www.mypharma-editions.com/?p=23227 http://www.mypharma-editions.com/biotechs-rhenovia-pharma-ouvre-sa-premiere-filiale-internationale-aux-etats-unis/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-confirme-la-dynamique-de-ses-fondamentaux-pour-2012 http://www.mypharma-editions.com/bioalliance-pharma-confirme-la-dynamique-de-ses-fondamentaux-pour-2012#comments Fri, 27 Jan 2012 14:02:27 +0000 morgdave http://www.mypharma-editions.com/?p=23224 http://www.mypharma-editions.com/bioalliance-pharma-confirme-la-dynamique-de-ses-fondamentaux-pour-2012/feed 0 http://www.mypharma-editions.com/novartis-prevoit-pour-2012-des-ventes-au-niveau-de-2011 http://www.mypharma-editions.com/novartis-prevoit-pour-2012-des-ventes-au-niveau-de-2011#comments Fri, 27 Jan 2012 08:27:20 +0000 morgdave http://www.mypharma-editions.com/?p=23222 http://www.mypharma-editions.com/novartis-prevoit-pour-2012-des-ventes-au-niveau-de-2011/feed 0 http://www.mypharma-editions.com/ipsen-prend-acte-du-deremboursement-de-tanakan-en-france http://www.mypharma-editions.com/ipsen-prend-acte-du-deremboursement-de-tanakan-en-france#comments Fri, 27 Jan 2012 07:47:57 +0000 morgdave http://www.mypharma-editions.com/?p=23220 http://www.mypharma-editions.com/ipsen-prend-acte-du-deremboursement-de-tanakan-en-france/feed 0 http://www.mypharma-editions.com/csis-2012-13-mesures-pour-un-secteur-strategique http://www.mypharma-editions.com/csis-2012-13-mesures-pour-un-secteur-strategique#comments Thu, 26 Jan 2012 10:27:32 +0000 morgdave http://www.mypharma-editions.com/?p=23214 http://www.mypharma-editions.com/csis-2012-13-mesures-pour-un-secteur-strategique/feed 3 http://www.mypharma-editions.com/csis-2012-le-leem-se-rejouit-de-la-continuite-du-dialogue-etat-industrie http://www.mypharma-editions.com/csis-2012-le-leem-se-rejouit-de-la-continuite-du-dialogue-etat-industrie#comments Thu, 26 Jan 2012 10:02:09 +0000 morgdave http://www.mypharma-editions.com/?p=23212 http://www.mypharma-editions.com/csis-2012-le-leem-se-rejouit-de-la-continuite-du-dialogue-etat-industrie/feed 1 http://www.mypharma-editions.com/vih-gilead-lance-un-essai-clinique-de-phase-2-evaluant-gs-7340 http://www.mypharma-editions.com/vih-gilead-lance-un-essai-clinique-de-phase-2-evaluant-gs-7340#comments Thu, 26 Jan 2012 09:27:02 +0000 morgdave http://www.mypharma-editions.com/?p=23210 http://www.mypharma-editions.com/vih-gilead-lance-un-essai-clinique-de-phase-2-evaluant-gs-7340/feed 0 http://www.mypharma-editions.com/le-site-de-linstitut-virtuel-des-metiers-et-des-formations-des-industries-de-sante-est-en-ligne http://www.mypharma-editions.com/le-site-de-linstitut-virtuel-des-metiers-et-des-formations-des-industries-de-sante-est-en-ligne#comments Thu, 26 Jan 2012 08:28:36 +0000 morgdave http://www.mypharma-editions.com/?p=23206 http://www.mypharma-editions.com/le-site-de-linstitut-virtuel-des-metiers-et-des-formations-des-industries-de-sante-est-en-ligne/feed 0 http://www.mypharma-editions.com/roche-lance-une-opa-hostile-sur-lamericain-illumina http://www.mypharma-editions.com/roche-lance-une-opa-hostile-sur-lamericain-illumina#comments Wed, 25 Jan 2012 10:04:09 +0000 morgdave http://www.mypharma-editions.com/?p=23188 http://www.mypharma-editions.com/roche-lance-une-opa-hostile-sur-lamericain-illumina/feed 0 http://www.mypharma-editions.com/vivalis-inaugure-un-laboratoire-dedie-a-sa-plateforme-de-decouverte-danticorps-monoclonaux-vivascreen http://www.mypharma-editions.com/vivalis-inaugure-un-laboratoire-dedie-a-sa-plateforme-de-decouverte-danticorps-monoclonaux-vivascreen#comments Wed, 25 Jan 2012 09:18:53 +0000 morgdave http://www.mypharma-editions.com/?p=23185 http://www.mypharma-editions.com/vivalis-inaugure-un-laboratoire-dedie-a-sa-plateforme-de-decouverte-danticorps-monoclonaux-vivascreen/feed 0 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires#comments Wed, 25 Jan 2012 08:43:54 +0000 morgdave http://www.mypharma-editions.com/?p=23183 http://www.mypharma-editions.com/diabete-de-type-2-roche-et-lihu-ican-partenaires-pour-identifier-des-voies-de-signalisation-et-des-cibles-moleculaires/feed 0 http://www.mypharma-editions.com/merck-serono-feu-vert-de-lue-pour-une-extension-dindication-de-rebif http://www.mypharma-editions.com/merck-serono-feu-vert-de-lue-pour-une-extension-dindication-de-rebif#comments Wed, 25 Jan 2012 08:23:41 +0000 morgdave http://www.mypharma-editions.com/?p=23179 http://www.mypharma-editions.com/merck-serono-feu-vert-de-lue-pour-une-extension-dindication-de-rebif/feed 0 http://www.mypharma-editions.com/csis-2012-christian-lajoux-invite-mercredi-25-janvier-sur-bfm-business http://www.mypharma-editions.com/csis-2012-christian-lajoux-invite-mercredi-25-janvier-sur-bfm-business#comments Tue, 24 Jan 2012 15:20:06 +0000 morgdave http://www.mypharma-editions.com/?p=23176 http://www.mypharma-editions.com/csis-2012-christian-lajoux-invite-mercredi-25-janvier-sur-bfm-business/feed 0 http://www.mypharma-editions.com/santhera-et-ipsen-renegocient-leur-accord-de-licence-sur-le-fipamezole http://www.mypharma-editions.com/santhera-et-ipsen-renegocient-leur-accord-de-licence-sur-le-fipamezole#comments Tue, 24 Jan 2012 08:28:37 +0000 morgdave http://www.mypharma-editions.com/?p=23166 http://www.mypharma-editions.com/santhera-et-ipsen-renegocient-leur-accord-de-licence-sur-le-fipamezole/feed 0 http://www.mypharma-editions.com/genzyme-la-fda-approuve-a-son-tour-le-site-de-production-de-framingham http://www.mypharma-editions.com/genzyme-la-fda-approuve-a-son-tour-le-site-de-production-de-framingham#comments Tue, 24 Jan 2012 08:04:45 +0000 morgdave http://www.mypharma-editions.com/?p=23163 http://www.mypharma-editions.com/genzyme-la-fda-approuve-a-son-tour-le-site-de-production-de-framingham/feed 0 http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique#comments Mon, 23 Jan 2012 17:22:09 +0000 morgdave http://www.mypharma-editions.com/?p=23158 http://www.mypharma-editions.com/bioalliance-pharma-deux-nouvelles-etapes-cles-pour-sa-biotherapie-amep-dans-le-melanome-metastatique/feed 0 http://www.mypharma-editions.com/mdxhealth-recoit-pour-son-laboratoire-clinique-la-certification-clia-et-la-licence-de-letat-de-californie http://www.mypharma-editions.com/mdxhealth-recoit-pour-son-laboratoire-clinique-la-certification-clia-et-la-licence-de-letat-de-californie#comments Mon, 23 Jan 2012 14:26:48 +0000 morgdave http://www.mypharma-editions.com/?p=23146 http://www.mypharma-editions.com/mdxhealth-recoit-pour-son-laboratoire-clinique-la-certification-clia-et-la-licence-de-letat-de-californie/feed 0 http://www.mypharma-editions.com/celgene-corporation-elit-le-dr-richard-w-barker-a-son-conseil-dadministration http://www.mypharma-editions.com/celgene-corporation-elit-le-dr-richard-w-barker-a-son-conseil-dadministration#comments Mon, 23 Jan 2012 12:45:13 +0000 morgdave http://www.mypharma-editions.com/?p=23139 http://www.mypharma-editions.com/celgene-corporation-elit-le-dr-richard-w-barker-a-son-conseil-dadministration/feed 0 http://www.mypharma-editions.com/industries-de-sante-une-etude-sur-les-competences-et-les-metiers-en-ile-de-france-a-horizon-2015 http://www.mypharma-editions.com/industries-de-sante-une-etude-sur-les-competences-et-les-metiers-en-ile-de-france-a-horizon-2015#comments Mon, 23 Jan 2012 08:32:53 +0000 morgdave http://www.mypharma-editions.com/?p=23126 http://www.mypharma-editions.com/industries-de-sante-une-etude-sur-les-competences-et-les-metiers-en-ile-de-france-a-horizon-2015/feed 0 http://www.mypharma-editions.com/avis-favorable-du-chmp-pour-remicade-en-europe-pour-la-rectocolite-hemorragique-chez-les-patients-pediatriques http://www.mypharma-editions.com/avis-favorable-du-chmp-pour-remicade-en-europe-pour-la-rectocolite-hemorragique-chez-les-patients-pediatriques#comments Mon, 23 Jan 2012 07:58:16 +0000 morgdave http://www.mypharma-editions.com/?p=23122 http://www.mypharma-editions.com/avis-favorable-du-chmp-pour-remicade-en-europe-pour-la-rectocolite-hemorragique-chez-les-patients-pediatriques/feed 0 http://www.mypharma-editions.com/la-fda-met-a-jour-letiquetage-de-tysabri-natalizumab http://www.mypharma-editions.com/la-fda-met-a-jour-letiquetage-de-tysabri-natalizumab#comments Mon, 23 Jan 2012 07:52:00 +0000 morgdave http://www.mypharma-editions.com/?p=23119 http://www.mypharma-editions.com/la-fda-met-a-jour-letiquetage-de-tysabri-natalizumab/feed 0 http://www.mypharma-editions.com/gilenya-lema-lance-une-reevaluation-du-rapport-beneficesrisques http://www.mypharma-editions.com/gilenya-lema-lance-une-reevaluation-du-rapport-beneficesrisques#comments Fri, 20 Jan 2012 15:16:54 +0000 morgdave http://www.mypharma-editions.com/?p=23112 http://www.mypharma-editions.com/gilenya-lema-lance-une-reevaluation-du-rapport-beneficesrisques/feed 0 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012#comments Fri, 20 Jan 2012 13:08:17 +0000 morgdave http://www.mypharma-editions.com/?p=23108 http://www.mypharma-editions.com/recherche-et-innovation-le-lir-presente-ses-grandes-orientations-pour-2012/feed 0 http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation#comments Fri, 20 Jan 2012 12:44:05 +0000 morgdave http://www.mypharma-editions.com/?p=23100 http://www.mypharma-editions.com/innovation-et-sante-lap-hp-et-cdc-entreprises-signent-une-convention-de-cooperation/feed 0 http://www.mypharma-editions.com/vih-feu-vert-de-la-fda-pour-de-nouvelles-formulations-de-viread-pour-les-enfants-infectes http://www.mypharma-editions.com/vih-feu-vert-de-la-fda-pour-de-nouvelles-formulations-de-viread-pour-les-enfants-infectes#comments Fri, 20 Jan 2012 12:04:54 +0000 morgdave http://www.mypharma-editions.com/?p=23098 http://www.mypharma-editions.com/vih-feu-vert-de-la-fda-pour-de-nouvelles-formulations-de-viread-pour-les-enfants-infectes/feed 0 http://www.mypharma-editions.com/bayer-healthcare-pharmaceuticals-rejoint-le-lir http://www.mypharma-editions.com/bayer-healthcare-pharmaceuticals-rejoint-le-lir#comments Fri, 20 Jan 2012 09:42:52 +0000 morgdave http://www.mypharma-editions.com/?p=23090 http://www.mypharma-editions.com/bayer-healthcare-pharmaceuticals-rejoint-le-lir/feed 0 http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts#comments Fri, 20 Jan 2012 09:07:59 +0000 morgdave http://www.mypharma-editions.com/?p=23087 http://www.mypharma-editions.com/depression-resistante-astrazeneca-et-la-fondation-fondamental-mettent-en-place-un-reseau-de-centres-experts/feed 0 http://www.mypharma-editions.com/cancer-quintiles-investit-dans-une-nouvelle-societe-de-rd-de-biomarqueurs http://www.mypharma-editions.com/cancer-quintiles-investit-dans-une-nouvelle-societe-de-rd-de-biomarqueurs#comments Thu, 19 Jan 2012 13:29:01 +0000 morgdave http://www.mypharma-editions.com/?p=23084 http://www.mypharma-editions.com/cancer-quintiles-investit-dans-une-nouvelle-societe-de-rd-de-biomarqueurs/feed 0 http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc#comments Thu, 19 Jan 2012 13:22:46 +0000 morgdave http://www.mypharma-editions.com/?p=23082 http://www.mypharma-editions.com/hybrigenics-depose-une-demande-detude-clinique-pour-linecalcitol-dans-la-leucemie-lymphoide-chronique-llc/feed 0 http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns#comments Thu, 19 Jan 2012 09:11:07 +0000 morgdave http://www.mypharma-editions.com/?p=23078 http://www.mypharma-editions.com/pherecydes-pharma-obtient-un-financement-de-la-dga-pour-le-projet-pacoburns/feed 0 http://www.mypharma-editions.com/astellas-feu-vert-au-japon-pour-regnite-contre-le-syndrome-des-jambes-sans-repos http://www.mypharma-editions.com/astellas-feu-vert-au-japon-pour-regnite-contre-le-syndrome-des-jambes-sans-repos#comments Thu, 19 Jan 2012 09:00:04 +0000 morgdave http://www.mypharma-editions.com/?p=23074 http://www.mypharma-editions.com/astellas-feu-vert-au-japon-pour-regnite-contre-le-syndrome-des-jambes-sans-repos/feed 0 http://www.mypharma-editions.com/sanofi-pasteur-le-bresil-introduit-le-vaccin-polio-inactive-dans-son-programme-national-de-vaccination http://www.mypharma-editions.com/sanofi-pasteur-le-bresil-introduit-le-vaccin-polio-inactive-dans-son-programme-national-de-vaccination#comments Thu, 19 Jan 2012 07:52:32 +0000 morgdave http://www.mypharma-editions.com/?p=23068 http://www.mypharma-editions.com/sanofi-pasteur-le-bresil-introduit-le-vaccin-polio-inactive-dans-son-programme-national-de-vaccination/feed 0 http://www.mypharma-editions.com/takeda-va-supprimer-2100-emplois-en-europe-et-700-aux-etats-unis http://www.mypharma-editions.com/takeda-va-supprimer-2100-emplois-en-europe-et-700-aux-etats-unis#comments Wed, 18 Jan 2012 18:38:06 +0000 morgdave http://www.mypharma-editions.com/?p=23066 http://www.mypharma-editions.com/takeda-va-supprimer-2100-emplois-en-europe-et-700-aux-etats-unis/feed 1 http://www.mypharma-editions.com/quintiles-ouvre-un-centre-dexcellence-novateur-a-dalian-en-chine http://www.mypharma-editions.com/quintiles-ouvre-un-centre-dexcellence-novateur-a-dalian-en-chine#comments Wed, 18 Jan 2012 16:23:18 +0000 morgdave http://www.mypharma-editions.com/?p=23063 http://www.mypharma-editions.com/quintiles-ouvre-un-centre-dexcellence-novateur-a-dalian-en-chine/feed 0 http://www.mypharma-editions.com/alzheimer-pfizer-et-medivation-abandonnent-le-developpement-du-dimebon http://www.mypharma-editions.com/alzheimer-pfizer-et-medivation-abandonnent-le-developpement-du-dimebon#comments Wed, 18 Jan 2012 10:09:20 +0000 morgdave http://www.mypharma-editions.com/?p=23055 http://www.mypharma-editions.com/alzheimer-pfizer-et-medivation-abandonnent-le-developpement-du-dimebon/feed 0 http://www.mypharma-editions.com/maladies-infectieuses-vivalis-et-sanofi-pasteur-etendent-leur-accord-de-collboration http://www.mypharma-editions.com/maladies-infectieuses-vivalis-et-sanofi-pasteur-etendent-leur-accord-de-collboration#comments Wed, 18 Jan 2012 08:25:21 +0000 morgdave http://www.mypharma-editions.com/?p=23046 http://www.mypharma-editions.com/maladies-infectieuses-vivalis-et-sanofi-pasteur-etendent-leur-accord-de-collboration/feed 0 http://www.mypharma-editions.com/genzyme-son-site-de-production-de-framingham-approuve-par-les-autorites-europeennes http://www.mypharma-editions.com/genzyme-son-site-de-production-de-framingham-approuve-par-les-autorites-europeennes#comments Wed, 18 Jan 2012 08:16:58 +0000 morgdave http://www.mypharma-editions.com/?p=23043 http://www.mypharma-editions.com/genzyme-son-site-de-production-de-framingham-approuve-par-les-autorites-europeennes/feed 0 http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique#comments Tue, 17 Jan 2012 14:40:00 +0000 morgdave http://www.mypharma-editions.com/?p=23037 http://www.mypharma-editions.com/genethon-fulvio-mavilio-nomme-directeur-scientifique/feed 0 http://www.mypharma-editions.com/benzodiazepines-lafssaps-dresse-un-etat-des-lieux-de-la-consommation-en-france http://www.mypharma-editions.com/benzodiazepines-lafssaps-dresse-un-etat-des-lieux-de-la-consommation-en-france#comments Tue, 17 Jan 2012 08:41:55 +0000 morgdave http://www.mypharma-editions.com/?p=23031 http://www.mypharma-editions.com/benzodiazepines-lafssaps-dresse-un-etat-des-lieux-de-la-consommation-en-france/feed 0 http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle#comments Mon, 16 Jan 2012 16:53:08 +0000 morgdave http://www.mypharma-editions.com/?p=23025 http://www.mypharma-editions.com/troubles-auditifs-sanofi-et-aviesan-signent-un-accord-de-recherche-translationnelle/feed 0 http://www.mypharma-editions.com/michele-antonelli-nomme-vice-president-executif-et-directeur-general-ducb-france http://www.mypharma-editions.com/michele-antonelli-nomme-vice-president-executif-et-directeur-general-ducb-france#comments Mon, 16 Jan 2012 15:13:06 +0000 morgdave http://www.mypharma-editions.com/?p=23021 http://www.mypharma-editions.com/michele-antonelli-nomme-vice-president-executif-et-directeur-general-ducb-france/feed 0 http://www.mypharma-editions.com/nutrition-infantile-nestle-et-danone-candidats-au-rachat-de-la-division-de-pfizer http://www.mypharma-editions.com/nutrition-infantile-nestle-et-danone-candidats-au-rachat-de-la-division-de-pfizer#comments Mon, 16 Jan 2012 10:05:57 +0000 morgdave http://www.mypharma-editions.com/?p=23016 http://www.mypharma-editions.com/nutrition-infantile-nestle-et-danone-candidats-au-rachat-de-la-division-de-pfizer/feed 0 http://www.mypharma-editions.com/medicago-et-cellectis-collaborent-a-lamelioration-des-proteines-therapeutiques-grace-a-la-technologie-des-nucleases http://www.mypharma-editions.com/medicago-et-cellectis-collaborent-a-lamelioration-des-proteines-therapeutiques-grace-a-la-technologie-des-nucleases#comments Mon, 16 Jan 2012 08:01:52 +0000 morgdave http://www.mypharma-editions.com/?p=23009 http://www.mypharma-editions.com/medicago-et-cellectis-collaborent-a-lamelioration-des-proteines-therapeutiques-grace-a-la-technologie-des-nucleases/feed 0 http://www.mypharma-editions.com/novartis-va-supprimer-pres-de-2-000-emplois-aux-etats-unis http://www.mypharma-editions.com/novartis-va-supprimer-pres-de-2-000-emplois-aux-etats-unis#comments Fri, 13 Jan 2012 09:18:30 +0000 morgdave http://www.mypharma-editions.com/?p=23001 http://www.mypharma-editions.com/novartis-va-supprimer-pres-de-2-000-emplois-aux-etats-unis/feed 0 http://www.mypharma-editions.com/stallergenes-vise-une-croissance-de-5-a-7-en-2012 http://www.mypharma-editions.com/stallergenes-vise-une-croissance-de-5-a-7-en-2012#comments Fri, 13 Jan 2012 08:41:19 +0000 morgdave http://www.mypharma-editions.com/?p=22999 http://www.mypharma-editions.com/stallergenes-vise-une-croissance-de-5-a-7-en-2012/feed 2 http://www.mypharma-editions.com/covidien-mark-trudeau-nomme-president-du-segment-produits-pharmaceutiques http://www.mypharma-editions.com/covidien-mark-trudeau-nomme-president-du-segment-produits-pharmaceutiques#comments Thu, 12 Jan 2012 16:23:24 +0000 morgdave http://www.mypharma-editions.com/?p=22996 http://www.mypharma-editions.com/covidien-mark-trudeau-nomme-president-du-segment-produits-pharmaceutiques/feed 0 http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros#comments Thu, 12 Jan 2012 13:38:29 +0000 morgdave http://www.mypharma-editions.com/?p=22990 http://www.mypharma-editions.com/biotechnologies-inserm-transfert-initiative-leve-335-millions-deuros/feed 0 http://www.mypharma-editions.com/retraits-de-lots-de-medicaments-de-genopharm http://www.mypharma-editions.com/retraits-de-lots-de-medicaments-de-genopharm#comments Thu, 12 Jan 2012 08:32:36 +0000 morgdave http://www.mypharma-editions.com/?p=22983 http://www.mypharma-editions.com/retraits-de-lots-de-medicaments-de-genopharm/feed 0 http://www.mypharma-editions.com/maurice-chagnaud-prend-la-direction-des-operations-commerciales-de-teva-europe http://www.mypharma-editions.com/maurice-chagnaud-prend-la-direction-des-operations-commerciales-de-teva-europe#comments Wed, 11 Jan 2012 13:10:28 +0000 morgdave http://www.mypharma-editions.com/?p=22976 http://www.mypharma-editions.com/maurice-chagnaud-prend-la-direction-des-operations-commerciales-de-teva-europe/feed 2 http://www.mypharma-editions.com/phenylcetonurie-merck-serono-lance-une-etude-de-validation-du-1er-questionnaire-sur-la-qualite-de-vie http://www.mypharma-editions.com/phenylcetonurie-merck-serono-lance-une-etude-de-validation-du-1er-questionnaire-sur-la-qualite-de-vie#comments Wed, 11 Jan 2012 09:00:29 +0000 morgdave http://www.mypharma-editions.com/?p=22973 http://www.mypharma-editions.com/phenylcetonurie-merck-serono-lance-une-etude-de-validation-du-1er-questionnaire-sur-la-qualite-de-vie/feed 0 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche#comments Tue, 10 Jan 2012 17:54:17 +0000 morgdave http://www.mypharma-editions.com/?p=22969 http://www.mypharma-editions.com/oncologie-matwin-transfere-son-premier-projet-de-recherche-a-roche/feed 0 http://www.mypharma-editions.com/ipsogen-acquier-les-droits-exclusifs-et-mondiaux-sur-deux-nouveaux-biomarqueurs http://www.mypharma-editions.com/ipsogen-acquier-les-droits-exclusifs-et-mondiaux-sur-deux-nouveaux-biomarqueurs#comments Tue, 10 Jan 2012 17:47:25 +0000 morgdave http://www.mypharma-editions.com/?p=22964 http://www.mypharma-editions.com/ipsogen-acquier-les-droits-exclusifs-et-mondiaux-sur-deux-nouveaux-biomarqueurs/feed 0 http://www.mypharma-editions.com/le-leem-au-16eme-mondial-des-metiers-a-lyon-du-2-au-5-fevrier-2012 http://www.mypharma-editions.com/le-leem-au-16eme-mondial-des-metiers-a-lyon-du-2-au-5-fevrier-2012#comments Tue, 10 Jan 2012 13:58:59 +0000 morgdave http://www.mypharma-editions.com/?p=22961 http://www.mypharma-editions.com/le-leem-au-16eme-mondial-des-metiers-a-lyon-du-2-au-5-fevrier-2012/feed 0 http://www.mypharma-editions.com/biotechs-sanofi-investit-dans-warp-drive-bio-une-start-up-americaine http://www.mypharma-editions.com/biotechs-sanofi-investit-dans-warp-drive-bio-une-start-up-americaine#comments Tue, 10 Jan 2012 13:23:17 +0000 morgdave http://www.mypharma-editions.com/?p=22951 http://www.mypharma-editions.com/biotechs-sanofi-investit-dans-warp-drive-bio-une-start-up-americaine/feed 2 http://www.mypharma-editions.com/industrie-du-medicament-reunion-du-csis-a-lelysee-le-25-janvier http://www.mypharma-editions.com/industrie-du-medicament-reunion-du-csis-a-lelysee-le-25-janvier#comments Tue, 10 Jan 2012 09:54:10 +0000 morgdave http://www.mypharma-editions.com/?p=22947 http://www.mypharma-editions.com/industrie-du-medicament-reunion-du-csis-a-lelysee-le-25-janvier/feed 1 http://www.mypharma-editions.com/epilepsie-premiers-resultats-positifs-dans-letude-phase-ii-sur-vimpat-ducb http://www.mypharma-editions.com/epilepsie-premiers-resultats-positifs-dans-letude-phase-ii-sur-vimpat-ducb#comments Mon, 09 Jan 2012 08:42:04 +0000 morgdave http://www.mypharma-editions.com/?p=22943 http://www.mypharma-editions.com/epilepsie-premiers-resultats-positifs-dans-letude-phase-ii-sur-vimpat-ducb/feed 0 http://www.mypharma-editions.com/hepatite-c-bristol-myers-squibb-acquiert-inhibitex-pour-25-milliards-de-dollars http://www.mypharma-editions.com/hepatite-c-bristol-myers-squibb-acquiert-inhibitex-pour-25-milliards-de-dollars#comments Sun, 08 Jan 2012 15:08:32 +0000 morgdave http://www.mypharma-editions.com/?p=22941 http://www.mypharma-editions.com/hepatite-c-bristol-myers-squibb-acquiert-inhibitex-pour-25-milliards-de-dollars/feed 1 http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs#comments Thu, 05 Jan 2012 08:27:09 +0000 morgdave http://www.mypharma-editions.com/?p=22929 http://www.mypharma-editions.com/neovacs-letude-clinique-de-phase-iia-dans-la-polyarthrite-rhumatoide-atteint-ses-objectifs/feed 1